Kyriacos Koupparis, Ph.D. - Publications
Affiliations: | 2012 | Biomedical Sciences | University of California, San Francisco, San Francisco, CA |
Area:
Parasitology Biology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2013 | Yedidi RS, Muhuhi JM, Liu Z, Bencze KZ, Koupparis K, O'Connor CE, Kovari IA, Spaller MR, Kovari LC. Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease. Biochemical and Biophysical Research Communications. 438: 703-8. PMID 23921229 DOI: 10.1016/j.bbrc.2013.07.117 | 0.76 | |||
2013 | Nishino M, Choy JW, Gushwa NN, Oses-Prieto JA, Koupparis K, Burlingame AL, Renslo AR, McKerrow JH, Taunton J. Hypothemicin, a fungal natural product, identifies therapeutic targets in Trypanosoma brucei Elife. 2013. PMID 23853713 DOI: 10.7554/eLife.00712 | 0.76 | |||
2012 | Mashiyama ST, Koupparis K, Caffrey CR, McKerrow JH, Babbitt PC. A global comparison of the human and T. brucei degradomes gives insights about possible parasite drug targets. Plos Neglected Tropical Diseases. 6: e1942. PMID 23236535 DOI: 10.1371/journal.pntd.0001942 | 0.76 | |||
2011 | Mackey ZB, Koupparis K, Nishino M, McKerrow JH. High-throughput analysis of an RNAi library identifies novel kinase targets in Trypanosoma brucei. Chemical Biology & Drug Design. 78: 454-63. PMID 21668652 DOI: 10.1111/j.1747-0285.2011.01156.x | 0.76 | |||
Show low-probability matches. |